Boston Scientific (BSX) Q2 2012 Earnings Call July 26, 2012 8:00 am ET Executives Sean Wirtjes William H. Kucheman - Chief Executive Officer, Director and Member of Finance Committee Jeffrey D. Capello - Chief Financial Officer and Executive Vice President Michael F. Mahoney - President Analysts Glenn J. Novarro - RBC Capital Markets, LLC, Research Division James Francescone - Morgan Stanley, Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division Bruce M. Nudell - Crédit Suisse AG, Research Division Kristen M. Stewart - Deutsche Bank AG, Research Division Daniel Sollof - Barclays Capital, Research Division Kevin Strange - Wells Fargo Securities, LLC, Research Division PresentationOperator
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Q2 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to our host, Mr. Sean Wirtjes. Please go ahead. Sean Wirtjes Thank you, Linda. Good morning, everyone, and thanks for joining us. With me on today's call are Hank Kucheman, Chief Executive Officer; and Jeff Capello, Executive Vice President and Chief Financial Officer. We issued a press release earlier this morning announcing our Q2 2012 results, which included key financials and reconciliations of the non-GAAP financial measures used in the release. We posted a copy of that press release, as well as reconciliations of the non-GAAP financial measures used in today's conference call to the comparable GAAP measures and other supporting schedules to the Investor Relations section of our website under the heading Financial Information.